Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GRSi is a premier technology and professional services firm that provides high-end health IT, bioinformatics, and clinical research support to the federal health sector. As a primary partner to the National Institutes of Health (NIH), the company delivers mission-critical solutions in data science, cybersecurity, and cloud infrastructure to accelerate biomedical discovery. GRSi supports a wide array of institutes, including the National Cancer Institute and the National Heart, Lung, and Blood Institute, by managing complex research environments and high-performance computing systems. Following its acquisition by DLH Holdings Corp. in 2022, GRSi continues to operate as a key pillar of DLH's digital transformation strategy for government health agencies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GRSi.